MyJournals Home  

RSS FeedsComparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery (Epidemiologic Perspectives & Innovations)

 
 

22 may 2015 05:31:38

 
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery (Epidemiologic Perspectives & Innovations)
 


Background: The aim of this study was to evaluate the effectiveness and safety of rivaroxaban for preventing venous thromboembolism (VTE) after lumbar spine surgery. Methods: In this randomized, controlled study, 665 patients who underwent lumbar surgery were randomly assigned to receive either rivaroxaban or parnaparin. Rivaroxaban and parnaparin were used for preventing postoperative venous thrombosis. The occurrence of postoperative efficacy endpoint events (venous thrombosis) and safety endpoint events (hemorrhage) was compared for each group. Results: Efficacy endpoint results: in the rivaroxaban group, there were 6 thrombotic events (1.7 %), 2 cases with severe VTE (0.6 %), and 3 cases with symptomatic VTE (0.9 %). In the parnaparin group, there were 10 thrombotic events (3.1 %), 4 cases with severe VTE (1.2 %), and 6 cases with symptomatic VTE (1.9 %). Safety endpoint results: in the rivaroxaban group, there were 21 cases with bleeding events (6.2 %), 2 cases with severe bleeding (0.6 %), and 19 cases with non-severe bleeding (5.6 %). In the parnaparin group, there were 21 bleeding events (6.2 %), 1 case with severe bleeding (0.3 %), and 16 cases with non-severe bleeding (4.9 %). The incidences of thromboembolic events, including severe and symptomatic VTE, were not significantly different between the two groups (P > 0.05). Bleeding event rates, including severe and non-severe bleeding, were also not significantly different. Conclusions: Rivaroxaban proved to be equally effective as parnaparin for anticoagulation therapy, with both drugs exhibiting a similar prevention effect against postoperative VTE after lumbar spine surgery, without increasing the risk of postoperative bleeding.


 
137 viewsCategory: Pathology, Virology
 
Holidays, celebrations, and commiserations: measuring drinking during feasting and fasting to improve national and individual estimates of alcohol consumption (Epidemiologic Perspectives & Innovations)
Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer (Epidemiologic Perspectives & Innovations)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Virology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten